Form 8-K - Current report:
SEC Accession No. 0001564590-20-017812
Filing Date
2020-04-22
Accepted
2020-04-22 07:15:23
Documents
3
Period of Report
2020-04-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K clsd-8k_20200421.htm 8-K 41678
2 EX-99.1 clsd-ex991_6.htm EX-99.1 10008
3 GRAPHIC g4y42ogvzn10000001.jpg GRAPHIC 2751
  Complete submission text file 0001564590-20-017812.txt   56925
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37783 | Film No.: 20806636
SIC: 2834 Pharmaceutical Preparations